A130010J15Rik Activators
A130010J15Rik Activators are a suite of chemical compounds that enhance the activity of the protein A130010J15Rik through various signaling pathways. Compounds such as Forskolin and Isoproterenol function by increasing cellular cAMP levels, thereby activating protein kinase A (PKA) which may phosphorylate and enhance A130010J15Rik activity if it is a PKA substrate. Similarly, Ionomycin, by increasing intracellular calcium levels, could activate calcium/calmodulin-dependent kinases that phosphorylate A130010J15Rik, thus enhancing its activity within calcium-dependent signaling pathways. Phorbol 12-myristate 13-acetate (PMA) acts as a PKC activator and could lead to the activation of A130010J15Rik if it is a downstream target in the PKC signaling cascade. IBMX, by inhibiting the degradation of cAMP and cGMP, raises their concentrations, potentially leading to the activation of kinases that amplify A130010J15Rik function.
Additionally, Oligomycin's inhibition of ATP synthase may lead to the activation of AMP-activated protein kinase (AMPK), which could phosphorylate and activate A130010J15Rik if it interacts with AMPK-regulated pathways. Epinephrine, through its action on adrenergic receptors, also raises cAMP levels, further enhancing A130010J15Rik activity through PKA signaling. Nicotine's activation of nicotinic acetylcholine receptors may increase calcium signaling, which in turn could enhance A130010J15Rik activity if it is part of a calcium-responsive pathway
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
A calcium ionophore that increases intracellular calcium concentration. If A130010J15Rik is modulated by calcium-dependent kinases, such as CaMK, ionomycin could enhance A130010J15Rik's function by activating these kinases. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC), which may lead to the phosphorylation of downstream proteins that regulate A130010J15Rik activity if A130010J15Rik is part of a signaling pathway influenced by PKC. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
A non-selective inhibitor of phosphodiesterases, which increases intracellular cAMP and cGMP by preventing their degradation. This could indirectly enhance A130010J15Rik if it's regulated by cAMP/cGMP-dependent pathways. | ||||||
Oligomycin A | 579-13-5 | sc-201551 sc-201551A sc-201551B sc-201551C sc-201551D | 5 mg 25 mg 100 mg 500 mg 1 g | $179.00 $612.00 $1203.00 $5202.00 $9364.00 | 26 | |
An ATP synthase inhibitor that can cause a buildup of cellular ADP. ADP accumulation could lead to the activation of AMPK, which could enhance A130010J15Rik activity if A130010J15Rik is regulated by AMPK-related pathways. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Acts on adrenergic receptors to increase cAMP production, which could enhance A130010J15Rik activity if A130010J15Rik is modulated by cAMP-dependent signaling pathways. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
A calcium channel agonist that increases calcium influx, potentially activating calcium-dependent kinases that could enhance A130010J15Rik function if it is modulated by such kinases. | ||||||
Diazoxide | 364-98-7 | sc-200980 | 1 g | $300.00 | 5 | |
Opens ATP-sensitive potassium channels, which could affect the membrane potential and indirectly lead to the activation of signaling pathways that enhance A130010J15Rik activity. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
Activates AMPK, which could enhance A130010J15Rik activity if A130010J15Rik is regulated by AMPK signaling pathways. | ||||||